update on tirzepatide lawsuit Lilly warns of 'impurity' in some compounded drugs FDA's tirzepatide decision creates uncertainty

Genomics, 22 (10), 741749

In the STEP 1 trial of the Wegovy injection, nausea affected around 44% of people, diarrhoea around 30%, and vomiting around 25%

Appetite regulation is the primary driver

Dont sign me up. Then, you know, I looked at it as a sport, you know, like, as an opponent, OK

(2) Across two different studies, patients who took semaglutide for 68 weeks saw a 9.6 17.4% reduction of initial body weight, while patients who took tirzepatide experienced weight loss effects ranging from 16.5% to 22.4% after a 72-week period

In this post, we will explore what happens after semaglutide and strategies to avoid weight regain